Publications by authors named "David A Gallagher"

Claim this Profile
T
The East London Parkinson's disease project - a case-control study of Parkinson's Disease in a diverse population.
Alexandra Zirra, Kamalesh C Dey, Ellen Camboe, Sheena Waters, Tahrina Haque, David A Gallagher

NPJ Parkinsons Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing and assessing a new web-based tapping test for measuring distal movement in Parkinson's disease: a Distal Finger Tapping test.
Noreen Akram, Haoxuan Li, Aaron Ben-Joseph, Caroline Budu, David A Gallagher

Sci Rep· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysautonomia Causing Severe Orthostatic Hypotension: An Important, Early Finding in Neurodegenerative Disorders.
Elizabeth Lovegrove, Gurvinder Rull, Mussadiq Shah, Peter O Julu, Christopher Wolff, David A Gallagher

JACC Case Rep· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between the MDS-UPDRS and Quality of Life: A large multicenter study of 3206 patients.
Matej Skorvanek, Pablo Martinez-Martin, Norbert Kovacs, Ivan Zezula, Mayela Rodriguez-Violante, David A Gallagher

Parkinsonism Relat Disord· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case report of neurosarcoidosis successfully treated with an infliximab biosimilar after a relapse while on dual therapy.
Dimos Merinopoulos, Fiona Hayes, David A Gallagher, Bhaskar Dasgupta

Clin Exp Rheumatol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in MDS-UPDRS Scores Based on Hoehn and Yahr Stage and Disease Duration.
Matej Skorvanek, Pablo Martinez-Martin, Norbert Kovacs, Mayela Rodriguez-Violante, Jean-Christophe Corvol, David A Gallagher

Mov Disord Clin Pract· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Why do patients with Parkinson's disease fall? A cross-sectional analysis of possible causes of falls.
Anette Schrag, Mahbuba Choudhury, Diego Kaski, David A Gallagher

NPJ Parkinsons Dis· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychosis, apathy, depression and anxiety in Parkinson's disease.
David A Gallagher, Anette Schrag

Neurobiol Dis· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the MDS-UPDRS Part I for nonmotor symptoms in Parkinson's disease.
David A Gallagher, Christopher G Goetz, Glenn Stebbins, Andrew J Lees, Anette Schrag

Mov Disord· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testing an aetiological model of visual hallucinations in Parkinson's disease.
David A Gallagher, Laura Parkkinen, Sean S O'Sullivan, Alexander Spratt, Ameet Shah

Brain· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them?
David A Gallagher, Andrew J Lees, Anette Schrag

Mov Disord· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Etiopathogenesis and treatment of Parkinson's disease.
David A Gallagher, Anthony H V Schapira

Curr Top Med Chem· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson's disease.
Shen-Yang Lim, Sean S O'Sullivan, Katya Kotschet, David A Gallagher, Cameron Lacey

J Clin Neurosci· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversible "Applause sign" secondary to diffuse large B cell lymphoma.
David A Gallagher, Jonathan M Schott, Anna Childerhouse, Thomas Wilhelm, Andrew N Gale

Mov Disord· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of newer pharmacological treatments on quality of life in patients with Parkinson's disease.
David A Gallagher, Anette Schrag

CNS Drugs· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonmotor symptoms as presenting complaints in Parkinson's disease: a clinicopathological study.
Sean S O'Sullivan, David R Williams, David A Gallagher, Luke A Massey, Laura Silveira-Moriyama

Mov Disord· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation. An analysis of published case series.
David A Gallagher, Sean S O'Sullivan, Andrew H Evans, Andrew J Lees, Anette Schrag

Mov Disord· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corticosteroid-induced osteoporosis in neurology patients.
David A Gallagher, Aaron Sturrock

Clin Neurol Neurosurg· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis